HEALTHBLOOMBERG
Island Pharma Jumps After Emergency-Use Approval for Ebola Drug
Island Pharma's stock increased following emergency-use approval for its Ebola drug. A health worker at Mulago National Referral Hospital in Kampala, Uganda, is depicted in the article's accompanying image.
Mentioned
Related Signal
Adjacent reporting
- Congo-Kinshasa: U.S. Releases Experimental Ebola Drug for DR Congo Outbreak Trials
- Congo Eurobonds Defy Ebola as Investors Chase Rare Yield, AI Exposure
- Shadow AI in Healthcare Is Here to Stay
- STAT+: AstraZeneca picks up FDA approval for hypertension drug
- Akeso To Boost Manufacturing Of Cancer Drug
- Starboard Builds Stake in Flowserve, Push for Changes